The Complex Role of Autophagy in Melanoma Evolution: New Perspectives From Mouse Models

Luca Di Leo1, Valérie Bodemeyer1, Daniela De Zio1

  • 1Cell Stress and Survival Unit, Center for Autophagy, Recycling and Disease (CARD), Danish Cancer Society Research Center, Copenhagen, Denmark.

Frontiers in Oncology
|January 31, 2020
PubMed

Insights

Autophagy, a cellular recycling process, is a promising target for melanoma treatment. Research highlights its role in cancer progression and potential therapeutic benefits, especially when studied using mouse models.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Melanoma remains a significant therapeutic challenge with poor patient survival rates.
  • Identifying novel therapeutic targets is crucial for improving melanoma treatment outcomes.
  • Autophagy, a cellular process, is increasingly recognized for its complex role in cancer.

Purpose of the Study:

  • To explore the multifaceted role of autophagy in melanoma development and progression.
  • To investigate the potential of autophagy as a therapeutic target for melanoma.
  • To highlight the utility of mouse models in studying autophagy in melanoma.

Main Methods:

  • Review of recent discoveries concerning autophagy in melanoma.
  • Focus on the application of genetically engineered mouse models (GEMMs) and syngeneic mouse models.
  • Analysis of autophagy's interplay with cellular metabolism and cancer hallmarks.

Main Results:

  • Autophagy is implicated in both melanomagenesis and tumor progression.
  • Autophagy influences key cancer cell characteristics like proliferation and metabolic rewiring.
  • Mouse models are essential tools for dissecting autophagy's contribution to melanoma.

Conclusions:

  • Autophagy plays a critical role in melanoma, influencing tumor growth and progression.
  • Targeting autophagy presents a potential therapeutic strategy for melanoma.
  • Further research utilizing advanced mouse models is vital for harnessing autophagy-based therapies.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K